CN102206694B - Slow-release composition containing capric acid - Google Patents

Slow-release composition containing capric acid Download PDF

Info

Publication number
CN102206694B
CN102206694B CN 201110085101 CN201110085101A CN102206694B CN 102206694 B CN102206694 B CN 102206694B CN 201110085101 CN201110085101 CN 201110085101 CN 201110085101 A CN201110085101 A CN 201110085101A CN 102206694 B CN102206694 B CN 102206694B
Authority
CN
China
Prior art keywords
capric acid
slow releasing
releasing composition
daptomycin
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110085101
Other languages
Chinese (zh)
Other versions
CN102206694A (en
Inventor
赵志全
郭朝江
王成
王召娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lunan New Era Biological Technology Co., Ltd.
Original Assignee
Shandong New Time Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong New Time Pharmaceutical Co Ltd filed Critical Shandong New Time Pharmaceutical Co Ltd
Priority to CN 201110085101 priority Critical patent/CN102206694B/en
Publication of CN102206694A publication Critical patent/CN102206694A/en
Application granted granted Critical
Publication of CN102206694B publication Critical patent/CN102206694B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention belongs to the field of biomedicine, and relates to a slow-release composition containing capric acid, particularly application of a slow-release composition containing capric acid in preparation of Daptomycin by fermentation. A certain amount of the slow-release composition containing capric acid can be supplemented at a specific time in the Daptomycin fermentation and production process, thereby synthesizing the Daptomycin. The invention reduces the number of times of shake flask fermentation and material supplementation, and lowers the probability of microbiological contamination; the slow-release capric acid reduces the toxicity for bacteria, and ensures good growth conditions for bacteria; and compared with the traditional batch-by-batch material supplementation method,the unit of the shake flask fermentation is increased by 4.1-5.8 times.

Description

A kind of slow releasing composition that contains capric acid
Technical field
The invention belongs to biomedicine field, related to a kind of slow releasing composition that contains capric acid, relate in particular to a kind of slow releasing composition that contains capric acid and prepare the application in the method for daptomycin in fermentation.
Background technology
Daptomycin (Daptomycin) (chemical formula one is the chemical formula of daptomycin) is to extract the cyclic ester peptide matters obtained in streptomycete (S.reseosporus) fermented liquid, it not only has novel chemical structure, and its binding mode is also from arbitrary to have got permission microbiotic different: it can destroy the bacterial cell membrane function in many aspects, kills rapidly thus gram positive organism.The daptomycin decapacitation acts on outside most of clinical relevant gram positive organisms, the more important thing is in vitro and still to have a strong active to being the resistance isolated strains such as X-1497 (Methicillin), vancomycin and Linezolid.
Figure GDA0000057769720000011
Chemical formula one
At present, daptomycin is mainly by fermentative Production, and needs in process of production to add the precursor substance capric acid, yet within the adding and need to be controlled at certain level of capric acid, when the capric acid excessive concentration, before high toxicity, know from experience and make thalli growth be subject to certain inhibition; And capric acid concentration is when low, under-supply, the daptomycin synthetic ratio is low.Lu Wenyu etc. are at " Fed-Batch Fermentative Production of Daptomycin by Decanoic Acid Resistance Mutant " (University Of Tianjin's journal, 2006, the 39th phase, the 20-24 page) disclose at the fermentor tank of 7.5L and produced, adopt the technique of continuous flow feeding to eliminate the restraining effect of precursor, the daptomycin for preparing gained is tired as 210mg/L.More than continue three grade in " Streptomyces roseosporus NRRL113789 produces the fermention medium optimization of daptomycin precursor thing A21978C " (Agriculture of Anhui science, 2008, the 36th the 19th phase of volume, the 7974-7976 page) disclose in a literary composition in shake flask fermentation and improved daptomycin output by optimizing fermention medium, the fermentation unit of final A21978C component is 60mg/mL, for the daptomycin after the A21978C bio-modification, does not disclose related data.
To sum up can learn, the pertinent literature that shake flask fermentation prepares daptomycin is not disclosed at present, and add capric acid in the shake flask fermentation process owing to can not realizing automatization trace flow feeding continuously, generally adopt repeatedly feed supplement, so not only easily cause the fermentation microbiological contamination, and because the capric acid excessive concentration suppresses thalli growth, thereby make fermentation unit lower.
Summary of the invention
The invention provides a kind of slow releasing composition that contains capric acid, percentage ratio meter by weight, the component that it contains following significant quantity: capric acid 3.0~10.0%, ethanol 3.0~8.0%, stearic acid 0.5~1.0%, polyoxyethylene glycol 1.0~2.0%, agar powder 1.0~2.0%, water 77.0~91.5%; More preferably capric acid 6%, ethanol 6%, stearic acid 0.7%, polyoxyethylene glycol (PEG) 1.1%, agar powder 1.2%, water 85%.
The present invention also provides the preparation method of this slow releasing composition, and its step is as follows:
Figure GDA0000057769720000021
take each component of slow releasing composition;
Figure GDA0000057769720000022
the capric acid taken is mixed to degerming with ethanol;
Figure GDA0000057769720000023
by proportioning, the stearic acid, polyoxyethylene glycol, agar powder and the water that take are mixed to high-temperature sterilization;
Figure GDA0000057769720000024
under aseptic condition by degerming capric acid and alcohol mixeding liquid add
Figure GDA0000057769720000025
in mixed solution, mix;
Figure GDA0000057769720000026
will under aseptic condition
Figure GDA0000057769720000027
mixed solution splashes in 0~10 ℃ of aseptic dimethyl silicone oil, makes sustained-release dropping pill;
Figure GDA0000057769720000028
the sustained-release dropping pill prepared is sucked to surperficial oil with aseptic paper, and cryopreservation.
The present invention also provides this slow releasing composition to prepare the application in the method for daptomycin in fermentation, in the liquid nutrient medium that contains assimilable carbon and nitrogen sources and inorganic salt, carry out under the aerobic fermentation condition, in specified time adds nutrient solution by a certain amount of slow releasing composition that contains capric acid, thereby improve the daptomycin combined coefficient.The method that fermentation provided by the present invention prepares daptomycin comprises following steps:
A. Streptomyces roseosporus is inoculated on slant medium, in 30 ℃ of aerobic cultivations 10 days;
B. the bacterium of step a being cultivated is inoculated on the 20-50ml liquid seed culture medium in 28-32 ℃, 220rpm shaking culture 30-48h;
C. the bacterium of b being cultivated is inoculated in fermention medium by inoculum size 2-10%, and 30 ℃, 220rpm shaking culture 8 days;
D. cultivate 20-48h from inoculation fermentation and start to add the slow releasing composition that contains capric acid, every liter of fermented liquid is per hour added the slow releasing composition containing the 0.1-0.4ml capric acid, at interval of 24-72h, adds once, until fermentation 204h finishes;
E. adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect at interval of the 24h sampling after adding precursor;
F. 24h microscopy after feed supplement for the first time, during fermentation ends, the centrifugal survey relative biomass of 3000rpm.
The present invention has carried out preferably the slant culture based formulas in step a, and preferably, in above-mentioned steps a, slant medium consists of: yeast extract 4g/L, malt extract 10g/L, glucose 4g/L, agar 15g/L.
The present invention has carried out preferably the seed culture based formulas in step b, and preferably, in above-mentioned steps b, seed culture medium consists of: dextrin 20g/L, peptone 10g/L, yeast extract 3g/L, K 2hPO 40.1g/L, NaCl 0.2g/L.
The present invention has carried out preferably the fermentative medium formula in step c, and preferably, in above-mentioned steps c, fermention medium consists of: dextrin 30g/L, glucose 6g/L, soyflour 15g/L, yeast powder 4g/L, FeSO 47H 2o 0.5g/L, K 2hPO 40.2g/L, MgSO 47H 2o 0.1g/L.
The present invention has carried out preferably the time of origin of adding of slow releasing composition, preferably, above-mentionedly cultivates 20~36h from inoculation fermentation and starts to add the slow releasing composition that contains capric acid.
Carried out the interval time that the present invention adds slow releasing composition preferably, preferably, the above-mentioned slow releasing composition that once contains capric acid of adding at interval of 24~48h.
The present invention has carried out preferably the additional amount of slow releasing composition, and preferably, above-mentioned, every liter of fermented liquid is per hour added the slow releasing composition containing the 0.15-0.3ml capric acid.
The present invention compared with prior art has advantages of following outstanding:
(1) fermentation prepares in the process of daptomycin and adds the slow releasing composition that contains capric acid provided by the invention, reduces the number of times of adding of capric acid, greatly reduces the microbiological contamination probability;
(2) due to the slow releasing composition that contains capric acid provided by the invention, it is a kind of sustained-release materials, slow release by capric acid, alleviated the toxicity of capric acid to thalline in the fermenting process, guaranteed that thalline growth conditions in building-up process is good, 24h microscopy after feed supplement for the first time, visible mycelia is thicker, longer, color depth; During fermentation ends, the fermented liquid thickness;
(3) greatly improved the fermentation unit that shaking flask prepares daptomycin, the present invention's fermentation prepares tiring of daptomycin and is increased to 101.7mg/L, is up to 137.1mg/L, and the method for preparing daptomycin than traditional zymotic improves 4.1-5.8 doubly.
Embodiment
Further illustrate by the following examples the present invention, but these embodiment do not limit the present invention in any way.
Embodiment 1: the preparation method of the slow releasing composition that contains capric acid
Figure GDA0000057769720000031
slow releasing composition proportioning (weight percentage):
Capric acid (%) Ethanol (%) Stearic acid (%) Polyoxyethylene glycol (%) Agar powder (%) Water (%)
Composition 1 3 3 0.5 1.0 1.0 91.5
Composition 2 10 8 1.0 2.0 2.0 77.0
Composition 3 6 6 0.7 1.1 1.2 85.0
Figure GDA0000057769720000032
by proportioning, the capric acid taken is mixed to the membrane filtration degerming with ethanol;
Figure GDA0000057769720000041
by proportioning, the stearic acid, polyoxyethylene glycol, agar powder and the water that take are mixed to 115 ℃ of mixed solutions, sterilizing 20min;
Figure GDA0000057769720000042
will on aseptic operating platform the aseptic mixed solution that obtains joins temperature and is down to 70 ℃
Figure GDA0000057769720000044
in mixed solution, mix;
Figure GDA0000057769720000045
will on aseptic operating platform
Figure GDA0000057769720000046
mixed solution splashes into through 121 ℃, and sterilizing 15min is cooled in the dimethyl silicone oil of 4 ℃, makes sustained-release dropping pill;
Figure GDA0000057769720000047
the sustained-release dropping pill prepared is sucked to surperficial oil with aseptic paper, and be stored in 4 ℃ of refrigerators standby.
Embodiment 2: the preparation of fermention medium
Slant medium (g/L): yeast extract 4, malt extract 10, glucose 4, agar 15, become feed liquid by formulated, adjusts pH7.2,121 ℃ of sterilizing 30min;
Seed culture medium (g/L): dextrin 20, peptone 10, yeast extract 3, K 2hPO 40.1 NaCl 0.2, by formulated, becomes feed liquid, adjusts pH7.0,121 ℃ of sterilizing 30min;
Fermentative medium formula (g/L): dextrin 30, glucose 6, soyflour 15, yeast powder 4, FeSO 47H 2o 0.5, K 2hPO 40.2, MgSO 47H 2o 0.1, by formulated, becomes feed liquid, adjusts pH7.2,121 ℃ of sterilizing 30min.
Embodiment 3: add the capric acid fermentation and prepare daptomycin
A. Streptomyces roseosporus NRRL11379 is inoculated on slant medium, in 30 ℃ of aerobic cultivations 10 days;
B. the bacterium of step a being cultivated is inoculated on the 30m1 seed culture medium, in 30 ℃, 220rpm shaking culture 48h;
C. the bacterium of b being cultivated is inoculated in fermention medium by inoculum size 8%, 30 ℃, 220rpm shaking culture 8 days;
D. cultivate 36h from fermentation and start to add capric acid, every liter of fermented liquid is once added the mixed solution (contain capric acid and ethanol in this mixed solution, and its weight ratio being 1: 1) that contains the 3.6ml capric acid, at interval of 24h, adds once, until fermentation 204h finishes, add altogether 6 times;
E. adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 20.1mg/L of fermentation ends daptomycin unit after adding capric acid at interval of the 24h sampling;
F. 24h microscopy after feed supplement for the first time: mycelia is thin, and painted light, fracture is serious; During fermentation ends, fermented liquid is rare, and the centrifugal survey relative biomass of 3000rpm is 12%.
Embodiment 4: the method for preparing daptomycin
Steps d starts to add for from fermentation, cultivating 36h the slow releasing composition that contains capric acid, and every liter of fermented liquid is once added the slow releasing composition that contains the 7.2ml capric acid, at interval of 48h, adds once, until fermentation 204h finishes, adds altogether 3 times.
All the other steps are with embodiment 3.
Adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 133.6mg/L of fermentation ends daptomycin unit after adding slow releasing composition at interval of the 24h sampling; 24h microscopy after feed supplement for the first time: mycelia is thicker, longer, color depth; During fermentation ends, the fermented liquid thickness, the centrifugal survey relative biomass of 3000rpm is 21%.
Embodiment 5: the method for preparing daptomycin
Steps d starts to add for from fermentation, cultivating 36h the slow releasing composition that contains capric acid, and every liter of fermented liquid is once added the slow releasing composition that contains the 10.8ml capric acid, at interval of 72h, adds once, until fermentation 204h finishes, adds altogether 2 times.
All the other steps are with embodiment 3.
Adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 101.7mg/L of fermentation ends daptomycin unit after adding slow releasing composition at interval of the 24h sampling; 24h microscopy after feed supplement for the first time: mycelia is thin, longer, painted shallow, the mycelia fracture; During fermentation ends, fermented liquid is than thickness, and the centrifugal survey relative biomass of 3000rpm is 19%.
Embodiment 6: the method for preparing daptomycin
Steps d starts to add for from fermentation, cultivating 30h the slow releasing composition that contains capric acid, and every liter of fermented liquid is once added the slow releasing composition that contains the 5.4ml capric acid, at interval of 36h, adds once, until fermentation 204h finishes, adds altogether 4 times.
All the other steps are with embodiment 3.
Adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 137.1mg/L of fermentation ends daptomycin unit after adding slow releasing composition at interval of the 24h sampling; 24h microscopy after feed supplement for the first time: mycelia is thicker, longer, color depth; During fermentation ends, the fermented liquid thickness, the centrifugal survey relative biomass of 3000rpm is 22%.
Embodiment 7: the method for preparing daptomycin
Steps d starts to add for from fermentation, cultivating 20h the slow releasing composition that contains capric acid, and every liter of fermented liquid is once added the slow releasing composition that contains the 3.2ml capric acid, at interval of 32h, adds once, until fermentation 204h finishes, adds altogether 5 times.
All the other steps are with embodiment 3.
Adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 135.3mg/L of fermentation ends daptomycin unit after adding slow releasing composition at interval of the 24h sampling; 24h microscopy after feed supplement for the first time: mycelia is thicker, longer, color depth; During fermentation ends, the fermented liquid thickness, the centrifugal survey relative biomass of 3000rpm is 21%.
Embodiment 8: the method for preparing daptomycin
Steps d starts to add for from fermentation, cultivating 36h the slow releasing composition that contains capric acid, and every liter of fermented liquid is once added the slow releasing composition that contains the 14.4ml capric acid, at interval of 48h, adds once, until fermentation 204h finishes, adds altogether 3 times.
All the other steps are with embodiment 3.
Adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 135.2mg/L of fermentation ends daptomycin unit after adding slow releasing composition at interval of the 24h sampling; 24h microscopy after feed supplement for the first time: mycelia is thicker, longer, color depth; During fermentation ends, the fermented liquid thickness, the centrifugal survey relative biomass of 3000rpm is 22%.
Embodiment 9: the method for preparing daptomycin
Steps d starts to add for from fermentation, cultivating 48h the slow releasing composition that contains capric acid, and every liter of fermented liquid is once added the slow releasing composition that contains the 9.6ml capric acid, at interval of 24h, adds once, until fermentation 204h finishes, adds altogether 5 times.
All the other steps are with embodiment 3.
Adopt Shimadzu LC-20A liquid chromatograph to detect daptomycin, detect the 134.9mg/L of fermentation ends daptomycin unit after adding slow releasing composition at interval of the 24h sampling; 24h microscopy after feed supplement for the first time: mycelia is thicker, longer, color depth; During fermentation ends, the fermented liquid thickness, the centrifugal survey relative biomass of 3000rpm is 20%.

Claims (9)

1. a slow releasing composition that contains capric acid is characterized in that: percentage ratio meter by weight, and it is comprised of the component of following significant quantity: capric acid 3.0~10.0%, ethanol 3.0~8.0%, stearic acid 0.5~1.0%, polyoxyethylene glycol 1.0~2.0%, agar powder 1.0~2.0%, water 77.0~91.5%.
2. slow releasing composition according to claim 1 is characterized in that: percentage ratio meter by weight, it is comprised of the component of following significant quantity: capric acid 6%, ethanol 6%, stearic acid 0.7%, polyoxyethylene glycol (PEG) 1.1%, agar powder 1.2%, water 85%.
3. a method for preparing slow releasing composition as claimed in claim 1 or 2 is characterized in that it comprises the following steps:
Figure FDA00003100768100011
take each component;
Figure FDA00003100768100012
the capric acid taken is mixed to degerming with ethanol;
Figure FDA00003100768100013
the stearic acid, polyoxyethylene glycol, agar powder and the water that take are mixed to high-temperature sterilization;
Figure FDA00003100768100014
under aseptic condition, the capric acid of degerming and alcohol mixeding liquid are added to step
Figure FDA00003100768100015
in mixture after high-temperature sterilization, mix;
Figure FDA00003100768100016
under aseptic condition by step
Figure FDA00003100768100017
mixed solution splashes in 0~10 ℃ of aseptic dimethyl silicone oil, makes sustained-release dropping pill;
Figure FDA00003100768100018
the sustained-release dropping pill prepared is sucked to surperficial oil with aseptic paper, and cryopreservation.
4. a method for preparing daptomycin is characterized in that it comprises following steps:
A. Streptomyces roseosporus is inoculated on slant medium, in 30 ℃ of aerobic cultivation 8-10 days;
B. the bacterium of step a being cultivated is inoculated on the 20-50ml liquid seed culture medium in 28-32 ℃, 220rpm shaking culture 36-50h;
C. the bacterium of b being cultivated is inoculated in fermention medium by inoculum size 2-10%, and 30 ℃, 220rpm shaking culture 8-10 days;
D. cultivate 20-48h from inoculation fermentation and start to add slow releasing composition as claimed in claim 1 or 2, add once at interval of 24-72h, until fermentation ends.
5. method according to claim 4, is characterized in that in step a, slant medium consists of: yeast extract 4g/L, malt extract 10g/L, glucose 4g/L, agar 15g/L.
6. method according to claim 4, is characterized in that in step b, seed culture medium consists of: dextrin 20g/L, peptone 10g/L, yeast extract 3g/L, K 2hPO 40.1g/L, NaCl 0.2g/L.
7. method according to claim 4, is characterized in that in step c, fermention medium consists of: dextrin 30g/L, glucose 6g/L, soyflour 15g/L, yeast powder 4g/L, FeSO 4 .7H 2o 0.5g/L, K 2hPO 40.2g/L, MgSO 4 .7H2O 0.1g/L.
8. method according to claim 4, is characterized in that cultivating 20h~36h from inoculation fermentation in steps d starts to add slow releasing composition as claimed in claim 1 or 2.
9. method according to claim 4, is characterized in that adding once slow releasing composition as claimed in claim 1 or 2 at interval of 24h~48h in steps d.
CN 201110085101 2011-04-06 2011-04-06 Slow-release composition containing capric acid Active CN102206694B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110085101 CN102206694B (en) 2011-04-06 2011-04-06 Slow-release composition containing capric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110085101 CN102206694B (en) 2011-04-06 2011-04-06 Slow-release composition containing capric acid

Publications (2)

Publication Number Publication Date
CN102206694A CN102206694A (en) 2011-10-05
CN102206694B true CN102206694B (en) 2013-10-16

Family

ID=44695754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110085101 Active CN102206694B (en) 2011-04-06 2011-04-06 Slow-release composition containing capric acid

Country Status (1)

Country Link
CN (1) CN102206694B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102703551A (en) * 2012-06-27 2012-10-03 中国药科大学 Novel method for adding decanoic acid in fermentation process of daptomycin
CN102796680B (en) * 2012-07-04 2018-06-05 鲁南新时代生物技术有限公司 A kind of Streptomyces roseosporus and its method for producing Daptomycin using precursor is combined

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053330A2 (en) * 2000-01-20 2001-07-26 Cubist Pharmaceuticals, Inc. High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
WO2002056829A2 (en) * 2000-12-18 2002-07-25 Cubist Pharmaceuticals, Inc. Methods for preparing purified daptomycin
WO2003014297A2 (en) * 2001-08-06 2003-02-20 Cubist Pharmaceuticals, Inc. Compositions and methods relating to the daptomycin biosynthetic gene cluster
CN101189253A (en) * 2004-11-12 2008-05-28 丘比斯特药物股份有限公司 Antiinfective lipopeptides
CN101824452A (en) * 2010-01-14 2010-09-08 天津大学 Batch type feed-batch fermentation method for streptomyces roseosporus to produce Daptomycin efficiently
CN101880703A (en) * 2010-06-23 2010-11-10 福建省微生物研究所 Method for fermenting daptomycin by adding caprate

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053330A2 (en) * 2000-01-20 2001-07-26 Cubist Pharmaceuticals, Inc. High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
WO2002056829A2 (en) * 2000-12-18 2002-07-25 Cubist Pharmaceuticals, Inc. Methods for preparing purified daptomycin
CN1982330A (en) * 2000-12-18 2007-06-20 卡比斯特制药公司 Methods for preparing purified lipopeptides
WO2003014297A2 (en) * 2001-08-06 2003-02-20 Cubist Pharmaceuticals, Inc. Compositions and methods relating to the daptomycin biosynthetic gene cluster
CN101189253A (en) * 2004-11-12 2008-05-28 丘比斯特药物股份有限公司 Antiinfective lipopeptides
CN101824452A (en) * 2010-01-14 2010-09-08 天津大学 Batch type feed-batch fermentation method for streptomyces roseosporus to produce Daptomycin efficiently
CN101880703A (en) * 2010-06-23 2010-11-10 福建省微生物研究所 Method for fermenting daptomycin by adding caprate

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
余继叁 等.玫瑰孢链霉菌NRRL11379产达托霉素前体物A21978C的发酵培养基优化.《安徽农业科学》.2008,
卢文玉 等.癸酸抗性突变株流加发酵法生产达托霉素.《天津大学学报》.2006,
玫瑰孢链霉菌NRRL11379产达托霉素前体物A21978C的发酵培养基优化;余继叁 等;《安徽农业科学》;20081231;7974-7976 *
癸酸抗性突变株流加发酵法生产达托霉素;卢文玉 等;《天津大学学报》;20060630;20-24 *

Also Published As

Publication number Publication date
CN102206694A (en) 2011-10-05

Similar Documents

Publication Publication Date Title
US9404163B2 (en) Pseudomonas putida strain as well as its microbial inoculum and application
CN101603066B (en) Method for preparing acarbose
CN108676755B (en) Microbial liquid fertilizer containing bacillus and preparation method and application thereof
CN105112476A (en) Method for producing lipopeptide biosurfactant by fermentation
CN102936608B (en) Method for producing avilamycin by fermenting
CN101967182A (en) Antimicrobial compound and preparation method and application thereof
CN103882080A (en) Effective method for preparing avermectin
CN104388500A (en) Method for high density fermentation of spinosad
CN102229968A (en) Method for cumulatively producing Sirolimus by using streptomyces hygroscopicus
CN102206694B (en) Slow-release composition containing capric acid
US11377670B2 (en) Method for preparing vanillin by fermentation with eugenol as substrate
CN102796680B (en) A kind of Streptomyces roseosporus and its method for producing Daptomycin using precursor is combined
CN106868079B (en) Culture medium for fermenting polymyxin B sulfate and method for producing polymyxin B sulfate through fermentation
CN110106115B (en) Bacillus subtilis synergist and application thereof in preparation of bacillus subtilis microbial inoculum
CN112831437A (en) Bacillus subtilis and fermentation method for high yield of indoleacetic acid and high spore formation rate
CN104531798A (en) Method for improving output of tetraene macrolide antibiotics
CN103966138A (en) Paracoccus bengalensis N74-1 and application thereof in aquaculture water purification
CN109055284B (en) Marine acid-producing strain for wine brewing and application thereof
CN109207536B (en) Method for increasing content of milbemycin A3 in milbemycin fermentation product
CN105671102A (en) Method of preparing ascomycin through fermentation
CN110468051B (en) K252A fermentation medium and preparation method thereof
CN103555610B (en) Streptomyces toxytricini for high yield of lipstatin and fermentation medium thereof
CN106497848B (en) Bacillus subtilis culture medium, preparation method thereof and culture method of bacillus subtilis
CN104498552A (en) Method for improving yield of epsilon-polylysine by low pH value stress
CN112795487B (en) Fermentation medium and fermentation method for producing fusidic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151218

Address after: Shandong province Linyi city Feixian County North Ring Road No. 1

Patentee after: Lunan New Era Biological Technology Co., Ltd.

Address before: 273400 Shandong city of Linyi province Feixian County North Ring Road No. 1

Patentee before: Shandong Xinshidai Pharmaceutical Industry Co., Ltd.